Top 200 Orgs
Top Orgs by Specialty
How We Rank
What's My Rank?
What's My Popularity Score?
In My Orgs?
In My Specialities?
In My Geography?
In My Age?
My Mentors, Collaborators,
Associates, Peers, Buddies
Keep Me Up To Date
People Making News
Latest Research From
People of Consequence (61416)
1. Peter Kowey
2. Lawrence W. Bassett
University of California
3. Robert S Kerbel
University of Toronto
4. Yehuda Shoenfeld
Sheba Medical Center
5. Paul Weiss
Gala Biotech business unit of Cardinal Health
Orgs of Consequence (17752)
Terms of Consequence
University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
Presented at Events Covering:
Biology, Biotechnology, Cancer Biology, Cell Biology, Epidemiology, Genomics, Hematology, Hepatology, Histology, Immunology, Leukemia, Microscopy, Molecular Biology, Oncology, Peptides, Pharmacology, Proteomics, Stem Cells, Translational Research
Areas of Interest:
BSN Rank: 271 / 619
Accomplish Score: 403
Popularity Score: 6
# in My Circle: 0
# in My Org(s): 22
We'll Post Your CV for Free!
Speaking/Presenting-Abstract/Poster at Mtg: 14 (182 / 0)
Building on the Success of CTLA-4 Blockade Through Biomarker Analyses and Development of Novel Combinatorial Strategies Chairperson: Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY (2013)
Combination co-stimulatory modulation: Moving from mouse to man (2013)
Systemic 4-1BB activation induces a novel T-cell phenotype driven by high expression of Eomesodermin (2012)
Honors and Awards: 7 (70 / 0)
MSKCC Immunology Program Post-doctoral Publication Award (2011)
iSBTc (SITC) Annual Meeting Presidential Award (2010)
IDEC/Genentech/Ronald Levy Postdoctoral Fellowship Award (2001 - 2004)
Clinical Trial Activity: 0 (0 / 0)
Grant Support: 2 (18 / 0)
MSKCC Society Genitourinary Malignancy Grant (2010 - 2012)
Patents Pending: 0 (0 / 0)
Journal - Editor/Reviewer: 0 (0 / 0)
Peer Reviewed Papers, Books, Chapters: 19 (114 / 0)
Gene Delivery Using Lentiviral Vectors (2014)
Systemic 4-1BB activation induces a novel T-cell phenotype driven by high expression of Eomesodermin (2013)
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-ÎºB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model (2012)
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
Membership in Professional Societies: 6 (18 / 0)
American Association of Immunologists (2011)
Society for Immunotherapy of Cancer (2010)
American Association for Cancer Research (2007)
White Papers: 0 (0 / 0)
Registered on BiotechScienceNews: 1
Advertise With Us
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.
Copyright © 2008 Biotech Science News LLC. All rights reserved